Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07198802
What this trial is testing

Molecular Research on Predictive Efficacy and New Therapeutic Targets for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 600
Testing effectiveness (Phase 2)UnknownNCT00004094
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01447056
What this trial is testing

Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases

Who this might be right for
Hodgkin LymphomaNon-Hodgkin LymphomaLymphoproliferative Disorder+3 more
Baylor College of Medicine 37
Large-scale testing (Phase 3)Active Not RecruitingNCT04456322
What this trial is testing

Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 381
Not applicableLooking for participantsNCT05946577
What this trial is testing

Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study

Who this might be right for
Head CancerNeck Cancer
Assistance Publique - Hôpitaux de Paris 140
Testing effectiveness (Phase 2)UnknownNCT02636231
What this trial is testing

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 96
Large-scale testing (Phase 3)Active Not RecruitingNCT07201337
What this trial is testing

Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 700
Testing effectiveness (Phase 2)Study completedNCT01271439
What this trial is testing

Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Study completedNCT00006248
What this trial is testing

S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 78
Testing effectiveness (Phase 2)Study completedNCT00003206
What this trial is testing

Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Looking for participantsNCT05854849
What this trial is testing

Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 244
Early research (Phase 1)Study completedNCT00006981
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07581821
What this trial is testing

Sintilimab Combined With Anlotinib and Taxane-Based Chemotherap for Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Recurrent or Metastatic Nasopharyngeal Carcinoma
Ming-Yuan Chen 33
Testing effectiveness (Phase 2)Study completedNCT00281840
What this trial is testing

Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 30
Large-scale testing (Phase 3)UnknownNCT03707509
What this trial is testing

Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 263
Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Testing effectiveness (Phase 2)Study completedNCT00101335
What this trial is testing

Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Who this might be right for
Head and Neck CancerPrecancerous Condition
Fox Chase Cancer Center
Large-scale testing (Phase 3)UnknownNCT03837808
What this trial is testing

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal NeoplasmsNasopharyngeal Diseases+1 more
Sun Yat-sen University 384
Large-scale testing (Phase 3)UnknownNCT02301208
What this trial is testing

Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
He Xia 120
Early research (Phase 1)UnknownNCT00004097
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI)
Next Page